These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8658803)

  • 1. Causes of hospital admission following successful renal transplantation.
    Kim HC; Joo I; Kwon JK; Suk J; Park SB
    Transplant Proc; 1996 Jun; 28(3):1603. PubMed ID: 8658803
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K; Munn SR; Sterioff S
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract]   [Full Text] [Related]  

  • 3. Sole immunosuppressive maintenance with cyclosporine A after heart transplantation.
    Koerner MM; Tenderich G; Mannebach H; zu Knyphausen E; Koertke H; Kleesiek K; Gleichmann U; Meyer H; Koerfer R
    Transplant Proc; 1996 Dec; 28(6):3119-21. PubMed ID: 8962209
    [No Abstract]   [Full Text] [Related]  

  • 4. Varicella-zoster infection in cyclosporine A-treated renal transplant patients.
    Lo CY; Cheng IK
    Transplant Proc; 1996 Jun; 28(3):1511-2. PubMed ID: 8658764
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of postdose cyclosporine monitoring in living renal transplant recipients.
    Thomas R; Minz M; Singh B; Heer M; Kashyap R
    Transplant Proc; 2004 Sep; 36(7):2104. PubMed ID: 15518761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension following renal transplantation.
    Kim HC; Joo I; Kwon JK; Suk J; Park SB
    Transplant Proc; 1996 Jun; 28(3):1486-7. PubMed ID: 8658753
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of renal transplantation at the Gdańsk Center.
    Zdrojewski Z; Rutkowski B; Lichodziejewska-Niemierko M; Debska-Slizień A; Bułło B; Gacyk W; Pirski MI; Zadrozny D; Moszkowska G
    Transplant Proc; 1996 Dec; 28(6):3492-3. PubMed ID: 8962358
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors after transplantation: are there associated factors?
    Jacobs U; Paar D; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3248. PubMed ID: 8962258
    [No Abstract]   [Full Text] [Related]  

  • 12. Kidney transplantation from living donors in Hungary: experience of 22 years.
    Perner F; Hidvégi M; Járay J; Alföldy F; Gyódi E; Petrányi G
    Transplant Proc; 1996 Dec; 28(6):3584-90. PubMed ID: 8962389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
    G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anti CD45 on different immunosuppressive regimes in renal transplantation.
    Talbot D; Shenton BK; Bell A; White M; Glennon A; Manas D; Minford E; Rix D; Mathew A; Kumar A; Taylor RM
    Transplant Proc; 1996 Dec; 28(6):3212-3. PubMed ID: 8999605
    [No Abstract]   [Full Text] [Related]  

  • 15. First experiences of pediatric kidney transplantation in Sri Lanka.
    Abeysekera CK; Gunasekara WD; Abegunawardena A; Buthpitiya AG; Lamawansa MD; Fernando O; Goonasekera CD
    Pediatr Transplant; 2007 Jun; 11(4):408-13. PubMed ID: 17493221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplantation from living donors in Italy.
    Berloco P; Pretagostini R; Poli L; Colonnello M; Alfani D; Cortesini R
    Transplant Proc; 1996 Dec; 28(6):3593-6. PubMed ID: 8962391
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.
    Min DI; Perry PJ; Chen HY; Hunsicker LG
    Pharmacotherapy; 1998; 18(2):282-7. PubMed ID: 9545147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.